Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.

Veterinary immunology and immunopathology - 1 Apr 2016

Ko Seong-sik, Seo Sang-won, Sunwoo Sun-young, Yoo Sung J, Kim Myung-hyee, Lyoo Young S

Abstract excerpt

Although several recent studies have found that type 1 porcine reproductive and respiratory syndrome virus (PRRSV) modified live virus (MLV) vaccine showed appreciable levels of cross-protection against type 2 PRRSV infection, the possibility of cross-protection between two genotype of PRRSV is still controversial. To determine potential protective efficacy against hetero-genotype field strain of PRRSV and to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Porcine Reproductive and Respiratory Syndrome

Share to Porcine respiratory and reproductive syndrome virus

Share to Specific Pathogen-Free Organisms

Share to Viral Vaccines

Source

Identifiers

PMID: 27032502
DOI: 10.1016/j.vetimm.2016.02.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.PMID 27032502Read ↗

Commercial PRRS Modified-Live Virus VaccinesSemantic proximity Read ↗

Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model.Semantic proximity Read ↗

Comparison of commercial type 1 and type 2 PRRSV vaccines against heterologous dual challenge.Semantic proximity Read ↗

Porcine Reproductive and Respiratory Syndrome Modified Live Virus Vaccine: A “Leaky” Vaccine with Debatable Efficacy and SafetySemantic proximity Read ↗

Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.Semantic proximity Read ↗

Current Status of Porcine Reproductive and Respiratory Syndrome VaccinesSemantic proximity Read ↗

Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus.Semantic proximity Read ↗

Improved Vaccine against PRRSV: Current Progress and Future PerspectiveSemantic proximity Read ↗

Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing PigsSemantic proximity Read ↗

Comparison of Host Immune Responses to Homologous and Heterologous Type II Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Challenge in Vaccinated and Unvaccinated PigsSemantic proximity Read ↗

Experimental evidence of vaccine-driven evolution of porcine reproductive and respiratory syndrome virus type 2Semantic proximity Read ↗

Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.